| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-10 |
MPA |
denotes |
Biomarkers |
| T1 |
14-37 |
CPA |
denotes |
Endothelial Dysfunction |
| T2 |
52-77 |
DISEASE |
denotes |
Polycystic Ovary Syndrome |
| T3 |
79-104 |
DISEASE |
denotes |
Polycystic ovary syndrome |
| T4 |
106-110 |
DISEASE |
denotes |
PCOS |
| T5 |
124-130 |
REG |
denotes |
common |
| T6 |
131-149 |
DISEASE |
denotes |
endocrine disorder |
| T7 |
359-386 |
GENE |
denotes |
adipocyte-secreted hormones |
| T8 |
424-447 |
CPA |
denotes |
endothelial dysfunction |
| T9 |
424-447 |
DISEASE |
denotes |
endothelial dysfunction |
| T10 |
451-455 |
DISEASE |
denotes |
PCOS |
| T11 |
590-600 |
MPA |
denotes |
biomarkers |
| T12 |
604-615 |
CPA |
denotes |
endothelial |
| T13 |
604-627 |
DISEASE |
denotes |
endothelial dysfunction |
| T14 |
629-637 |
GENE |
denotes |
visfatin |
| T15 |
629-637 |
GENE |
denotes |
visfatin |
| T16 |
639-647 |
GENE |
denotes |
vascular |
| T17 |
639-673 |
GENE |
denotes |
vascular endothelial growth factor |
| T18 |
648-659 |
GENE |
denotes |
endothelial |
| T19 |
675-679 |
GENE |
denotes |
VEGF |
| T20 |
682-708 |
GENE |
denotes |
matrix metalloproteinase 9 |
| T21 |
710-715 |
GENE |
denotes |
MMP-9 |
| T22 |
732-736 |
DISEASE |
denotes |
PCOS |
| T23 |
749-753 |
DISEASE |
denotes |
PCOS |
| T24 |
783-791 |
GENE |
denotes |
visfatin |
| T25 |
783-791 |
GENE |
denotes |
visfatin |
| T26 |
792-806 |
MPA |
denotes |
concentrations |
| T27 |
866-875 |
POSREG |
denotes |
increased |
| T28 |
876-880 |
GENE |
denotes |
VEGF |
| T29 |
881-891 |
MPA |
denotes |
production |
| T30 |
917-929 |
CPA |
denotes |
inflammation |
| T31 |
917-929 |
DISEASE |
denotes |
inflammation |
| T32 |
939-948 |
POSREG |
denotes |
increased |
| T33 |
949-954 |
GENE |
denotes |
MMP-9 |
| T34 |
955-969 |
MPA |
denotes |
concentrations |
| T35 |
986-993 |
REG |
denotes |
related |
| T36 |
1025-1038 |
REG |
denotes |
abnormalities |
| T37 |
1025-1049 |
DISEASE |
denotes |
abnormalities of ovarian |
| T38 |
1042-1070 |
CPA |
denotes |
ovarian extracellular matrix |
| T39 |
1083-1106 |
CPA |
denotes |
multiple cyst formation |
| T40 |
1108-1126 |
CPA |
denotes |
follicular atresia |
| T41 |
1108-1126 |
DISEASE |
denotes |
follicular atresia |
| T42 |
1140-1151 |
CPA |
denotes |
anovulation |
| T43 |
1156-1160 |
DISEASE |
denotes |
PCOS |
| T44 |
1170-1180 |
REG |
denotes |
associated |
| T45 |
1219-1230 |
CPA |
denotes |
endothelial |
| T46 |
1219-1242 |
DISEASE |
denotes |
endothelial dysfunction |
| R0 |
T1 |
T0 |
ThemeOf |
Endothelial Dysfunction,Biomarkers |
| R1 |
T2 |
T0 |
ThemeOf |
Polycystic Ovary Syndrome,Biomarkers |
| R10 |
T19 |
T11 |
ThemeOf |
VEGF,biomarkers |
| R11 |
T20 |
T11 |
ThemeOf |
matrix metalloproteinase 9,biomarkers |
| R12 |
T21 |
T11 |
ThemeOf |
MMP-9,biomarkers |
| R13 |
T22 |
T11 |
ThemeOf |
PCOS,biomarkers |
| R14 |
T22 |
T12 |
ThemeOf |
PCOS,endothelial |
| R15 |
T24 |
T26 |
ThemeOf |
visfatin,concentrations |
| R16 |
T26 |
T27 |
ThemeOf |
concentrations,increased |
| R17 |
T29 |
T27 |
ThemeOf |
production,increased |
| R18 |
T30 |
T27 |
ThemeOf |
inflammation,increased |
| R19 |
T27 |
T32 |
CauseOf |
increased,increased |
| R2 |
T2 |
T1 |
ThemeOf |
Polycystic Ovary Syndrome,Endothelial Dysfunction |
| R20 |
T27 |
T35 |
CauseOf |
increased,related |
| R21 |
T27 |
T36 |
CauseOf |
increased,abnormalities |
| R22 |
T27 |
T39 |
CauseOf |
increased,multiple cyst formation |
| R23 |
T27 |
T40 |
CauseOf |
increased,follicular atresia |
| R24 |
T27 |
T42 |
CauseOf |
increased,anovulation |
| R25 |
T28 |
T27 |
ThemeOf |
VEGF,increased |
| R26 |
T28 |
T29 |
ThemeOf |
VEGF,production |
| R27 |
T32 |
T30 |
CauseOf |
increased,inflammation |
| R28 |
T34 |
T32 |
ThemeOf |
concentrations,increased |
| R29 |
T32 |
T35 |
CauseOf |
increased,related |
| R3 |
T3 |
T5 |
ThemeOf |
Polycystic ovary syndrome,common |
| R30 |
T32 |
T36 |
CauseOf |
increased,abnormalities |
| R31 |
T32 |
T38 |
CauseOf |
increased,ovarian extracellular matrix |
| R32 |
T32 |
T39 |
CauseOf |
increased,multiple cyst formation |
| R33 |
T32 |
T40 |
CauseOf |
increased,follicular atresia |
| R34 |
T32 |
T42 |
CauseOf |
increased,anovulation |
| R35 |
T33 |
T32 |
ThemeOf |
MMP-9,increased |
| R36 |
T33 |
T34 |
ThemeOf |
MMP-9,concentrations |
| R37 |
T34 |
T35 |
ThemeOf |
concentrations,related |
| R38 |
T38 |
T36 |
ThemeOf |
ovarian extracellular matrix,abnormalities |
| R39 |
T40 |
T36 |
ThemeOf |
follicular atresia,abnormalities |
| R4 |
T4 |
T5 |
ThemeOf |
PCOS,common |
| R40 |
T42 |
T36 |
ThemeOf |
anovulation,abnormalities |
| R41 |
T39 |
T35 |
ThemeOf |
multiple cyst formation,related |
| R42 |
T39 |
T36 |
ThemeOf |
multiple cyst formation,abnormalities |
| R43 |
T40 |
T35 |
ThemeOf |
follicular atresia,related |
| R44 |
T43 |
T44 |
ThemeOf |
PCOS,associated |
| R45 |
T45 |
T44 |
ThemeOf |
endothelial,associated |
| R5 |
T10 |
T8 |
ThemeOf |
PCOS,endothelial dysfunction |
| R6 |
T12 |
T11 |
ThemeOf |
endothelial,biomarkers |
| R7 |
T14 |
T11 |
ThemeOf |
visfatin,biomarkers |
| R8 |
T16 |
T11 |
ThemeOf |
vascular,biomarkers |
| R9 |
T18 |
T11 |
ThemeOf |
endothelial,biomarkers |
